> >
Grant Recipients
 

1990 - Ongoing
Marrow Donor Drives
In collaboration with The New York Blood Center, New York, NY

1997 - Ongoing
Pain and Palliative Care Service
Sherry Schachter, PhD, CT
Calvary Hospital/Hospice, Bronx, NY
Service originally rendered at Memorial Sloan Kettering Cancer Center, New York, NY

 

 

 
2016
Prabodhika Mallikaratchy, PhD
CUNY-Lehman College, Bronx, NY
Design and Development of DNA Aptamer Based Immunotherapeutic
In memory of Muriel Fusfeld Grant made possible by Caryl Rubenfeld and The Muriel Fusfeld Foundation


Katrien Van Roosbroeck, PhD
University of Texas MD Anderson Cancer Center, Houston, TX
Role of MicroRNA’s in Aggressive Transformation of Chronic Lymphocytic Leukemia to Richter Syndrome

Akihide Yoshimi, MD. PhD
Memorial Sloan Kettering Cancer Center, New York, NY
Understanding the Collaborating Events Essential for IDH-Mutant Leukemogenesis
Grant is partially funded by Caryl Rubenfeld and The Muriel Fusfeld Foundation


Florencia Leticia Palacios. PhD
Feinstein Institute at Northwell Health, Manhasset, NY
Characterization of the Biological Function of Musashi2 RNA Binding Protein in Chronic Lymphocytic Leukemia
Grant made possible by Walter Kissinger in memory of Ambassador Felix Schnyder


Yusuke Tarumoto, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Identification of Genetic Dependencies and Therapeutic Targets in AML Grant made possible by Walter Kissinger in memory of Ambassador Felix Schnyder


2015
Yana Pikman, MD
Dana-Farber Cancer Center, Boston, MA
Targeting mitochondrial folate metabolism for novel acute myeloid Leukemia therapy

Olga A. Guryanova, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY
Novel treatment strategies for DNMT3A-mutant high-risk MDS

Peter K. Gregerson, MD & Kim Stimfendorfer, PhD
North Shore-LIJ Feinstein Institute for Medical Research, Manhasset, NY
Small Molecules targeting PTPN22-Csk interaction to alter immune signaling thresholds. In memory of Muriel Fusfeld Grant made possible by Caryl Rubenfeld and The Muriel Fusfeld Foundation

Andrea Nicola Mazzarello, PhD
North Shore-LIJ Feinstein Institute for Medical Research, Manhasset, NY
Immunoglobulin heavy chain isotype effects antibody reactivity and affinity and can lead to unabated B-cell stimulation in CLL Grant made possible by Walter Kissinger in memory of Ambassador Felix Schnyder

Yusuke Tarumoto, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Investigation of mechanism of epigenetic inhibitor-induced therapeutic activity Grant made possible by Walter Kissinger in memory of Ambassador Felix Schnyder


2014
Andrea Nicola Mazzarello, PhD
North Shore-LU Feinstein Institute for Medical Research
Associating Human Chronic Lymphocytic Leukemia
B-Cell Receptor Three-Dimensional Structure with
Epitope Binding
Grant made possible by Walter Kissinger in memory of Ambassador Felix Schnyder

Jon A. Oyer, PhD
Northwestern University
Consequences of the MMSET E1099K Mutation in Acute
Lymphoblastic Leukemia (ALL)

John Anto Pulikkan, PhD
University of Massachusetts Medical School
Targeted Therapy for Core Binding Factor Leukemia

Jae Seok Roe, PhD
Cold Spring Harbor Laboratory
Investigating p300-dependent Recruitment
Mechanism of Brd4

Grant made possible by Walter Kissinger in memory of
Ambassador Felix Schnyder

2013
Gerardo Ferrer, PhD
The Feinstein Institute for Medical Research
North Shore-LIJ Health Systems, Manhasset, NY

An in vivo analysis of the cellular interaction governing
the engraftment and growth of human chronic leukemia B Cells

The grant was made possible by Walter Kissinger and
The Ambassador Felix Schnyder Memorial Fund
In memory of Ambassador Felix Schynder

Koshi Akahane, MD
Dana Farber Cancer Institute, Boston MA
Significance of innate resistance to mitochondrial
Apoptosis in high-risk T-ALL

Faith Mercan, PhD
Cold Spring Harbor Laboratory
Cold Spring Harbor, NY

Engineering Peptide-Based Brd4 Bromodomain
Inhibitors using Phage Display

The grant was made possible by Walter Kissinger and
The Ambassador Felix Schnyder Memorial Fund
In memory of Ambassador Felix Schnyder


Kim Stimpfendorfer, PhD
The Feinstein Institute for Medical Research
North Shore-LIJ Health Systems, Manhasset, NY

Study of Characterization of proliferative and
Renewing cell populations in chronic CLL

The grant was made possible by Caryl Rubenfeld
of The Muriel Fusfeld Foundation
In memory of Muriel Fusfeld

2012
Shinpei Kawaoka, PhD
Cold Spring Harbor Laboratory Cold Spring Harbor, NY
Targeting Bromodomain Proteins in Acute Lymphoblastic Leukemia
Grant was made possible by Walter Kissinger and The Felix Schnyder Memorial Fund In memory of Ambassador Felix Schnyder

Rita Simone, PhD
The Feinstein Institute for Medical Research North Shore Manhasset, NY
A Novel Adoptive Transfer Model of Human Chronic Lymphocytic Leukemia Suggests a Key Role for T Lymphocytes in the Disease Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund In memory of Ambassador Felix Schnyder

Andrew Lane, MD, PhD
Dana Farber Cancer Institute, Boston, MA
Defining Chromosome 21 Loci that Promote Lymphoid Leukemogenesis.
In memory of Michael J. Lopez and Lauri Strauss


Kim Stimpfendorfer, PhD
The Feinstein Institute for Medical Research North Shore, Manhasset, NY
B Lymphocyte Kinase (Blk): A Risk Gene for Autoimmunity and T-Cell Leukemia Grant was made possible by Caryl Rubenfeld and the Muriel Fusfeld Foundation In memory of Muriel Fusfeld.

2011
Omar Abdel-Wahab, MD
Memorial Sloan Kettering Cancer Center, New York, NY
Role of ASXLI mutations in acute myelogenous leukemia
This Grant was made possible by Mary Jo and John Boler
In memory of Richard J. Giffels, Helen DeGulis and Patricia Winkel


Lyne Khair, PhD
University of Massachusetts Medical School, Worcester, Ma
Genome Wide DNA Breaks Induced by AID During B Cell Activation

Kim Stimpfendorfer, PhD
The Feinstein Institute for Medical Research North Shore – LIJ Health Systems, Manhasset, NY
B lymphocyte Kinase (Blk): a risk gene for autoimmunity and T cell leukemia
This grant was made possible by Caryl P. Rubenfeld and The Muriel Fusfeld Foundation.
In memory of Muriel Fusfeld


Rita Simone, PhD
The Feinstein Institute for Medical Research North Shore – LIJ Health Systems, Manhasset, NY
A Novel Adoptive Transfer Model of Human Chronic Lymphocytic Leukemia
Suggests a Key Role for T Lymphocytes in the Disease
This grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder

Emma Vernersson Lindahl, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Investigating the Impact of TAp63 on Hematopoietic Malignancies Utilizing
a Novel TAp63-Deficient Mouse Model.
   

2010
Davide Bagnara, PhD
The Feinstein Institute for Medical Research
North Shore-LIJ Health Systems, Manhasset, NY
Development of an Adoptive Transfer Model of Human Chronic Lymphocytic Leukemia
This Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund In Memory of Ambassador Felix Schnyder

Yuchen Chien, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Critical Contribution of NF-kB to Chemoresistance of Myc and Bc12 Driven Lymphoma in Mice
This Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund In Memory of Ambassador Felix Schnyder

Patricia Ernst, PhD
Dartmouth Medical School, Hanover, NH
Genetic and Biochemical Approaches to Targeting Mixed Lineage Leukemia

Monica L. Guzman, PhD
Joan & Sanford I. Weill Medical College of Cornell University, New York, NY
Targeting of Human Acute Myelogenous Leukemia Stem Cells

Rajesh R. Singh, PhD
University of Texas MD Anderson Cancer Center, Houston, Texas
Targeting Sonic Hedgehog Signaling to Overcome Chemoresistance in Diffuse Large B-Cell Lymphoma

Emily S. Tonorezos, MD, MPH
Sloan Kettering Institute for Cancer Research, New York, NY
Diet and Insulin in Survivors of Childhood Leukemia
This Grant was made possible
by MaryJo and John Boler
In Memory of Helen DeGulis, Richard J. Giffels, Donald George Uhlir, and Patricia Winkel.

2009
Ikbel Achour, PhD
University of Illinois at Chicago, Springfield, IL
Mechanisms of Chromosomal Translocation
In B Lymphocytes
This Grant was made possible
by Mary Jo and John Boler
In Memory of Richard J. Giffels

Shih-Shih Chen, PhD
Feinstein Institute for Medical Research
North Shore-LIJ Health Systems, Manhasset, NY
Role of B-cell Antigen Receptor Engagement in Chronic Lymphocytic Leukemia: Survival and Expansion Versus Anergy and Death
This Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder

Ya-Huei Kuo, PhD
Beckman Research Institute of City of Hope, Duarte, CA
Analysis and Targeting of Leukemia Stem Cells in Inv(16)-Associated Acute Myeloid Leukemia
This grant was made possible by Mary Jo and John Boler In Memory of Helen DeGulis

Cornelious Miething, MD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Study on the Role of PTEN in Tumorigenesis and Development of Chemoresistance in a MiR30-Based Transgene Murine Model of Conditional PEN Inactivation.
This Grant was made possible by Walter Kissinger and The Ambassador Felix Schnyder Memorial Fund
In Memory of Ambasador Felix Schnyder

Rushdia Yusuf, MD, MPH
Massachusetts General Hospital, Boston, Mass
The Role of UDP-Glucose in Protection of A Hematopoietic Stem Cells from Chemotherapy
This Grant was made possible
by MaryJo and John Boler
In Memory of Patricia WInkel

   
2008
Filiz Sen, MD
New York University School of Medicine, New York, NY

Title FBN7 Mutations in T Cell ALL
This Grant made possible by Mary Jo and John Boler
In Memory of Helen DeGulis

Angela Stoddart, PhD
The University of Chicago, Chicago, IL

Determining the Transforming Mechanism of the CLAM-AF10 fusion Protein: Does Defective
Endocytosis Synergize with Transcriptional Deregulation?
This Grant Made Possible by Mary Jo and John Boler

In Memory of Richard J. Giffels

Lili Wang, MD
University of Illinois at Chicago, Chicago, IL

Title Mechanisms of Chromosomal Translocation in B Lymphocytes
This Grant made possible by Mary Jo and John Boler

In Memory of Patricia Winkel

Eleana Levantini, PhD
Beth Israel Deaconess Medical Center, Boston, Mass

Development of transgenic models to mimic human leukemias: the BVR/ABL case
Ford Motor Company Fund and The Johnny Mercer Foundation for their assistance in making this grant possible.
Camile P. Semighini, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

Use of reversible RNA interference in transgenic mice to study the importance of RB and ATM in tumor
development, maintenance and response to therapy.
Ambassador Felix Schnyder Memorial Grant

In Memory of Ambassador Felix Schnyder

Carlo Calissano, MD
The Feinstein Institute for Medical Research,
North Shore – LIJ Health Systems, Manhasset, NY

Identification and characterization of chronic lymphocytic leukemia B cells and their normal B
lymphocyte counterpart
Ambassador Felix Schnyder Memorial Grant

In Memory of Ambassador Felix Schnyder

James L. LaBelle, M.D., PhD
Dana-Farber Cancer Institute, Boston, MA

Title Dismantling the Apoptotic Blockade of Refractory Leukemia by Pharmacologic Replacement of
the Tumor Suppressor BIM
This Grant Made Possible by Muriel Fusfeld Foundation
   
2007
Jan Andreas Burger, MD
M.D. Anderson Cancer Center, Houston, TX
Phosphoinositide 3-Kinases in Chemokine Receptor Signaling in Chronic Lymphocytic Leukemia
Made Possible by Mary Jo and John Boler

In Memory of Helen DeGulis

Javier Pinilla-Ibarz, MD, PhD
H. Lee Moffitt Cancer Center, Tampa, FL
Correlative Immunological Studies of a Pilot Trial With a WTl Analog Peptide Vaccine in
Patients With Myeloid Malignancies

Made Possible by Mary Jo and John Boler
In Memory of Richard J. Giffels


Monica Buzzai, PhD
Northwestern University Feinberg School of Medicine, Chicago, IL
Cell Survival and Proliferation Pathways Mediated by JAK2 Mutations in
Myeloproliferative Disorders (MPD) and Leukemia

Made Possible by Mary Jo and John Boler
In Memory of Patricia Winkel


B. Belinda Ding, PhD
Albert Einstein College of Medicine, Bronx, NY
Mechanism of STAT3 Activation in Diffuse Large B-cell Lymphoma
Made Possible by Ford Motor Company and The Johnny Mercer Foundation
In Memory of Johnny Mercer

Ramiro Garzon, MD
The Ohio State University, Columbus, OH
Role of MicroRNA in the Pathogenesis of Acute Myeloid Leukemia
Made Possible by the Friends of José Carreras International Leukemia Foundation

Rosa Catera, PhD
The Feinstein Institute for Medical Research
North Shore – LIJ Health System, Manhasset, NY
Bacterial Components as Epitopes for B-CLL Antibodies
Made Possible by the Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder


Timothy S. Pardee, MD, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
In Vitro Array Based Screening for Genes Involved in Chemoresistance and
Sensitivity in Acute Myelogenous Leukemia

Made Possible by the Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder

   
2006
Dong Hong Cai, MD, PhD
John Hopkins University, Baltimore, MD
Interaction Between C/EBPa and AP-1 in Myeloid Leukemogenesis
Grant made possible by Mary Jo and John Boler
In memory of Patricia Winkel


Scott Cameron, MD, PhD
U T Southwestern Medical Center, Dallas, TX
Mechanism of Programmed Cell Death in
MI1- positive Leukemia

Grant made possible by Mary Jo and John Boler
In Memory of Helen DeGulis


Nobuharu Fujii, MD, PhD
Fred Hutchinson Cancer Research Center, Seattle,WA
Transcription Factors in Hematopoietic Stem Cells As Targets For Leukemia Immunotherapy
Grant Made Possible by Mary Jo and John Boler
In Memory of Richard J. Giffels


Ann Jakubowski, MD, PhD
Memorial Sloan Kettering Cancer Center,
NY, NY

Clinical and Laboratory Studies of Keratinocyte
Growth Factor to Facilitate Immune Reconstitution in Patients Undergoing an Allergenic Stem Cell Transplant

Grant made possible by Alvin Marks
In Memory of Elaine Marks

Hanno Hock, MD, PhD
Massachusetts General Hospital, Boston, MA
Re-creation of Leukemogenic TEL-AML1
Fusion in Embryonic Hematopoiesis
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

H. Daniel Lacorazza, PhD, PI
Baylor College of Medicine, Dallas, TX
Regulation of ELF-4 Gene Expression
in Leukemic Cells

Grant made possible by Ford Motor Company
and by the Johnny Mercer Foundaton
In Memory of Johnny Mercer


Brian McCarthy, PhD
North Shore / Long Island Jewish Health System Manhasset, NY
Analysis of Patient Parameters Related to the
B-Cell Receptors to Chronic Lymphocytic
Leukemias

Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder


Johannes Zuber, MD
Cold Spring Harbor Labaoratory, Cold Spring Harbor,NY
In-Vivo Analysis of Key Genes and Mechanisms
of Resistance in the Therapy of Active Myeloid
Leukemia

Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

   
2005
Deepa Trivedi, MD
Memorial Sloan Kettering Cancer Center,
NY, NY

Generation of Cytomegalovirus (CMV) Specific
T- Lymphocytes using Protein Spanning Pools of Pentadecapeptides for Adoptive Immuno Therapy

Grant made possible by Mary Jo and John Boler
In Memory of Patricia Winkel


Farshid Dayyani, MD
Massachusetts General Hospital, Boston, MA
The Role of Groucho Family Co-Repressors TLE1 and TLE4 in Hematopoiesis and Leukemogenesis
Grant made possible by Mary Jo and John Boler
In Memory of Helen DeGulis


Manabu Shimoyama, MD, PhD
Mount Sinai School of Medicine, NY, NY
The Importance of the SET Domain and Histone
Methylation in Leukemia and Other Hematological
Malignancies

Grant made possible by Mary Jo and John Boler
In Memory of Donald George Uhlir, DVM


Florence Bernardin Fried, PhD
Johns Hopkins Hospital, Baltimore, MD
Regulation of Proliferation by the AML 1
Leukemia Oncoprotein

Grant made possible by Ford Motor Company

Daniel Ditzel Santos, MD
Dana Farber Cancer Center, Boston, MA
Targeting Mast Cells and Mast Cell Interactions in the Treatment of Waldenstrom’s Macroglobulinemia
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld


Claudia S. Huettner, PhD
Blood Center Institute of Blood Center of Wisconsin Milwaukee, WI
Role of Bcl-x Leukemogenesis by BCR/ABL
Grant made possible by The Johnny Mercer Foundation In Memory of Johnny Mercer

Enrique Cepero, PhD
Cold Spring Harbor Labarotory,
Cold Spring Harbor, NY

The Role of Caspases In Leukemia Suppression and Chemotherapy Response, In Vivo
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder


Santanu Paul, PhD
North Shore-Long Island Jewish Health Systems Manhasset, NY
Telomere Reconstruction in Chronic Lymphocytic Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

2004
Michelle A. Kelliher, PhD
University of Massachusetts Medical School
Department of Cancer Biology,
Worchester, MA

Mechanism(s) of TAL-1/SCL-Medicated
Leukemogenesis

Grant made possible by the Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld


Eyal Attar, MD
Massachusetts General Hospital, Boston, MA
Targeting Quiescent Leukemia Stem Cells via
Proteasome Inhibition

Grant made possible by Ford Motor Company

Anthony G. Brickner, PhD
University of Pittsburgh, Pittsburgh, PA
Identification of Graft-vs.-Leukemia Associated
Human Minor Histocompatibility Antigens

Grant made possible by The Johnny Mercer Foundation
In Memory of Johnny Mercer


Bradley Messmer, PhD
North Shore – Long Island Jewish
Research Institute, Manhasset, NY

Characterizing the Antigens Receptors Used by
B-CLL Cells

Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder


Clare Louise Scott, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor,NY

Identification of Genes Important in Drug-Induced Senescence in a Murine Eu-myc Lymphoma Model
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder


Patricia Yotnda, PhD
Baylor College of Medicine, Waco, TX
Directed Delivery of Oncolytic Adenovirus to
the Tumor Site by Tumor-Specific Cytotoxic L
Lymphocytes (CTL)

Michael J. Lopez Memorial Grant

   

2003
Danillo Perrotti, MD, PhD
James Cancer Hospital and Richard J. Solove
Research Institute, Ohio State University, Columbus,OH

Research initiated at Thomas Jefferson University, Philadelphia, PA
Role of BCR/ABL Oncogene in Suppression
of Neutrophilic Differentiation

Grant made possible by The Johnny Mercer Foundation
In Memory of Johnny Mercer


William Tse, MD
Case Western Reserve University School of Medicine, Cleveland, OH
Research Initiated at Fred Hutchinson
Cancer Research Center Clinical Significance of AF1q Gene in Myeloid and Lymphoid Leukemia

Grant made possible by Ford Motor Company

Loren D. Walensky, MD, PhD
Dana Farber Cancer Institute, Boston, MA
Targeting Apoptosis in Leukemia by Chemical Design
Grant made possible by Cell Therapeutics

Artur Slupianek, PhD
College of Science and Technology Center for Biotechnology, Temple University, Philadelphia, PA
Role of Rad51 Family Members in Drug Resistance Induced by BCR/ABL
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld


Emilia Albesiano, PhD
North Shore - Long Island Jewish
Research Institute, Manhasset, NY

Identification of Activation-Induction Cytidine
Deaminase Expression in B Cell Type Chronic
Lymphocytic Leukemia Cells

Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder


Susan Kambhampti, MD
Northwestern School of Medicine
Northwestern University, Chicago, IL

Role of Protein Kinase C-Delta in the Induction of All-Trans-Retinoic Acid Responses in APL Cells
Courtesy of the Madoff Family

Michael Hemann, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY

Improving the Characterization and Treatment of Leukemia and Lymphoma
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder


Nicholas Chiorazzi, MD in association with
Charles C. Chu, PhD

North Shore-Long Island Jewish
Research Institute, Manhasset, NY

Cellular and Molecular Characterization of the
Pathogenic Autoantibody-producing B Lymphocytes from Patients with Systematic Lupus Erythematosus

Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

2002
Benjamin Boettner, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor,NY

Identification and Characterization of Genes
Regulated by BCR-ABL, The Causative Agent of
Chronic Myelogenous Leukemia

Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder


Kevin D. Bunting, PhD
American Red Cross Holland Laboratory, Rockville,MD
Functional Characterization of the Role of the Novel Mixed Lineage Leukemia-Associated AFIq Gene Product in Myeloid Leukemia Cell Differentiation
Grant Made Possible by The Johnny Mercer Foundstion
In Memory of Johnny Mercer
Nicholas Chiorazzi, MD in association with


Charles C. Chu, PhD
Laboratory of Molecular Immunology/Gene
Activation, North Shore-Long Island Jewish
Research Institute, Manhasset, NY

Cellular and Molecular Characterization of the
Pathogenic Autoantibody-producing B
Lymphocytes from Patients with Systematic Lupus
Erythematosus

Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld


Yih-Pai Chu, PhD
North Shore-Long Island Jewish
Research Institute, Manhasset, NY

The Role of Tumor Necrosis Factor-alpha in the
Proliferation and Survival of the Leukemic Cells in B Cell Type Chronic Lymphocytic Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund

In Memory of Ambassador Felix Schnyder

Dilip Patel, MD
Long Island Jewish Medical Center,
New Hyde Park, NY

Initiation of Study of Familial Chronic
Lymphocytic Leukemia (CLL) Starting with a
Systematic Survey of CLL Patients Who Have a
First-Degree Relative with CLL or a Related
Lymphoid Disorder

In Honor of Kanti R. Rai, MD

Constantine Mitsiades, MD
Dana Farber Cancer Institute, Boston, MA
Biologically Based Therapeutic Strategies to
Enhance the Activity of TRIAL/Apo21 Against
Leukemias, Lymphomas and Myeloma

Grant made possible by Ford Motor Company

Joseph Schwartz, MD
Memorial Sloan Kettering Cancer Center,
NY, NY
Leukemia Immunotherapeutic Approaches Using the WT-1 Antigen as a Target
In Memory of Michael J. Lopez

Richard D. Huhn, MD
Coriell Institute for Medical Research, Camden, NJ
Studies of the Cellular Basis of Delayed Platelet
Engraftment Following Transplantation of Culture Expanded Cord Blood Stem/Progenitor Cells

In Memory of Michael Lopez
Grant Made Possible by The Muriel Fusfeld Fundation


Jeffrey M. Lipton, MD, PhD
Schneider Children’s Hospital,
New Hyde Park, NY

Financial Support for an Additional Childlife Specialist

   

2001
David M. Loeb, MD, PhD
Division of Pediatric Oncology
Johns Hopkins University, Baltimore, MD

The Role of WTI in Resistant AMI
In Memory of Michael J. Lopez

Nicholas Mitsiades, MD
Dana Farber Cancer Institute, Boston, MA
Biotherapy of B-Cell Malignancies by Trial
Medicated Apoptosis

Grant made possible by the Johnny Mercer Foundation
In Memory of Johnny Mercer


Andromachi Scaradavou, MD
New York Blood Center Lindsay K. Kimball Research Institute Laboratory of Immunogenetics, New York, NY
Material Microchimerism in Unrelated Placental
Cord Blood Recipients

Grant made possible by Ford Motor Company

Jordan Fridman, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Identification and Analysis of Drug Resistance
Mechanisms in Leukemia and Lymphoma

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Davorka Messmer, PhD
North Shore University Hospital,
Manhasset, NY

Generation of a CTL Response to B-CLL Cells
Using Tumor Antigen-Pulsed Dendritic Cells

Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

2000
Dr. Raymond Comenzo, MD
Memorial Sloan Kettering Cancer Center,
NY, NY

Study of the Use of Infusions of Stem Cells from Patients Following High-dose Chemotherapy or Radiation Therapy as an Alternative to Allogeneic Bone Marrow Transplant
In Memory of Louise Scheinberg

Erica Lerma, MD
Sidney Kimmel Cancer Center, San Diego, CA
Molecular Therapy of CML
In Memory of Michael J. Lopez

Jonathan Finlay, MB, ChB
New York University School of Medicine
Stephen D. Hassenfeld Center for Children’s Cancer and Blood Disorders
New York University Medical Center, NY, NY

Topotecan Phase I Clinical Trial for Leukemic,
Lymphomatous and Other Pediatric Neoplastic
Leptomeningeal Malignancies

In Honor of Adam Schwartz

Naoto Hirose, MD
North Shore University Hospital,
Manhasset, NY

Autoreactivity Maturation Stage in Gene
Expression in the Immunobiology and Clinical
Outcome of Chronic Lymphocytic Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund

In memory of Ambassador Felix Schnyder

B. Hilda Ye, PhD
Albert Einstein College of Medicine
Cancer Center, Bronx, NY

Role of the BCL-6 Oncogene in Lymphoma
Cell Lines


Scott Lowe, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor,NY
Molecular Basis of Drug Resistance in a
Mouse Model of Leukemia and Lymphoma
Grant made possible by The Ambassador Felix Schnyder Fund

In memory of Ambassador Felix Schnyder

Nicholas Chiorazzi, MD and Charles C. Chu, PhD
North Shore University Hospital,
Manhasset, NY

Determination of Human Fig 1
Polymorphisms in SLE Patients
Grant made possible by The Muriel Fusfeld Foundaton

In memory of Muriel Fusfeld

   

1999
Dominique Bonnet, PhD
Coriell Institute for Medical Research, Camden, NJ
Characterization of the Cell Cycle Status of
Acute Myeloid Stem Cells Using
NOD/SCID-Leukemia Model

In memory of Michael J. Lopez

Scott Dessain, MD, PhD
Thomas Jefferson University, Philadelphia, PA
The Telomerase Gene in Tumorigenesis and
Chronic Myelogenous Leukemia Research undertaken at Dana Farber/Partners Cancer Care Whitehead Institute for Biomedical Research, Boston, MA


Hao-peng Xu Duffy, PhD
Stonybrook University, Stonybrook, NY
Study of Multidrug Resistant Phenotype in
Leukemia


North Shore University Hospital,
Manhasset, NY

Research undertaken at Department of Molecular Oncology
Grant made possible by the Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Nicholas K. Tonks, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor,NY

Investigating Molecular Links to Chronic
Myelogenous Leukemia (CML)

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


1998
Arup Chakraborty, PhD
Children’s Nutrition Research Center, Houston, TX
Role of Stat3 in G-CSF-mediated Myeloid
Differentiation

In memory of Michael J. Lopez

Hao-peng Xu Duffy, PhD
Stonybrook University, Stonybrook, NY
Continuation of 1997 Grant
Research undertaken at Department of Molecular Oncology North Shore University Hospital,
Manhasset, NY
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Steven P. Treon, MD, PhD
Massachusetts General Hospital Dana Farber Cancer Institute Harvard Medical School, Boston, MA
Study of Muc-1 and Multiple Myeloma

Nicholas Tonks, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY

Continuation of 1997 Grant
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder

1997
Hao-peng Xu Duffy, MD, PhD
Stonybrook University, Stonybrook, NY
Study of Genomic Lesions in Chronic
Lymphocytic Leukemia Research undertaken at Department of Molecular Oncology
North Shore University Hospital,
Manhasset, NY

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Kenichi Takeshita, MD
Hematology Division, Department of Medicine
New York University Medical Center, NY, NY

Homeobox Gene Expression in Human Myeloid
Leukemia
In memory of Michael J. Lopez


Michael Tomasson, MD
Washington University School of Medicine
St. Louis, MO

Murine Models of Tyrosine Kinase Fusion Protein Mediated Leukemogenesis

Nicholas K. Tonks, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor,NY

Protein Tyrosine Phosphatases and Chronic
Myelogenous Leukemia

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


1996
Michael W. Schuster, MD
New York Weill Cornell Center, NY, NY
Research Undertaken at North Shore
University Hospital, Manhasset, NY

Extended Research was Performed on a Class of Drugs That Shuts Down a Leukemia Cell’s
Resistance to Cancer Killing Chemotherapy

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Naoko Tanese, PhD
Department of Microbiology NYU Medical Center, New York, NY
Analysis of Proteins Involved in Transcriptions and Oncogenesis
In memory of Michael J. Lopez

Nicholas K. Tonks, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor,NY

Pattern That Leads to Dysfunctional Maturation of Hematopoetic Stem Cells in CML
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Patricia Levy Yeyati, PhD
Brookdale Center, Mt. Sinai Hospital, NY, NY
Research undertaken at Mt. Sinai School of Medicine, NY,NY
Identification of Genes Regulated by the
Promyelocitic Leukemia Zinc Finger Protein

   

1995
Michael Gilman, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor,NY
Controlling Cell Growth in Lymphoid CLL
Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Elizabeth A. McGuire, MD
University of Pittsburgh Medical Center
Cancer Institute, Pittsburgh, PA

Functional Characterization of Ttgl, a LIM Domain of Oncogene in T-ALL

Michael W. Schuster, MD
New York Weill Cornell Center, New York, NY
Research Undertaken at North Shore University Hospital, Manhasset, NY
Purging Bone Marrow With Magnetic Beads
in Autologous BHT

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Richard Steinman, MD, PhD
University of Pittsburgh Medical Center
Cancer Institute, Pittsburgh, PA

The Role of p21 (WAF-1) to Hematopoietic Differential

1994
Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders
New York University Medical Center, NY, NY

Continuation of 1993 Grant
In honor of Adam Schwartz


Ursula Matulonis, MD
Harvard Medical School
Dana-Farber Cancer Institute, Boston, MA

Therapies to Block the Interaction of BCR-ABL with Proteins in CML Cell Growth

David A. Scheinberg, MD, PhD
Memorial Sloan Kettering Cancer Center,
NY, NY
Monoclonal Antibodies in Patients with ‘APL’

1993
Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders
New York University Medical Center,
NY, NY

These funds were applied in part to support
psycho-social services rendered to children with leukemia and other forms of cancer and their families, as well as to enable underinsured or uninsured children to receive optimal medical care at the Center.

In honor of Adam Schwartz

Florence Ajchenbaum, MD
Dana-Farber Cancer Institute, Boston, MA
Cancer Associated Genes’ Ability to Control Growth and Their Role in the Development of Leukemias

Steven Nimer, MD
Memorial Sloan Kettering Center, NY, NY
Molecular Targets to Develop Novel and Specific Methods of Diagnosing and Treating Acute Leukemia

1992
Verena Bier, MD
University of Heidelberg, Visiting Fogarty Fellow, National Cancer Institute,
Bethesda, MD

Gene Development and Cell Growth as They
Relate to the Formation of Leukemia


Kanti Rai, MD
Long Island Jewish Medical Center,
New Hyde Park, NY

Evaluation of New Drugs in CLL Continuation
of 1990 Grant


1991
Robert J. Fallon, MD, PhD
Riley Children’s Hospital, Indiana University
School of Medicine, Indianapolis, IN

Cell Related Abnormalities Occurring in
Early Stages of Cancer
Research undertaken at Pediatric Hematology/Oncology
and Stem Cell Transplants, Cardinal Glennon
Children’s Hospital, St. Louis School of Medicine, St. Louis, MO


Kanti R. Rai, MD
Long Island Jewish Medical Center,
New Hyde Park, NY

The Study of Chronic Lymphocytic Leukemia,
Including Evaluation of New Drugs


1990
Loren Walensky, MD
Resident, Children’s Hospital Medical Center
Boston, MA

Study undertaken at Princeton University
mentored by Professor Taylor - Research as a Summer

Fellow in Chemotherapeutic Development

Sujata Rao, MD
Fred Hutchinson Cancer Center, Seattle, WA
Research undertaken at Memorial Sloan Kettering Cancer Center, NY, NY

Purging in Bone Marrow Transplantation